Literature DB >> 24630794

Two miRNA clusters reveal alternative paths in late-stage reprogramming.

Ronald J Parchem1, Julia Ye1, Robert L Judson1, Marie F LaRussa1, Raga Krishnakumar1, Amy Blelloch2, Michael C Oldham3, Robert Blelloch4.   

Abstract

Ectopic expression of specific factors such as Oct4, Sox2, and Klf4 (OSK) is sufficient to reprogram somatic cells into induced pluripotent stem cells (iPSCs). In this study, we examine the paths taken by cells during the reprogramming process by following the transcriptional activation of two pluripotent miRNA clusters (mir-290 and mir-302) in individual cells in vivo and in vitro with knockin reporters. During embryonic development and embryonic stem cell differentiation, all cells sequentially expressed mir-290 and mir-302. In contrast, during OSK-induced reprogramming, cells activated the miRNA loci in a stochastic, nonordered manner. However, the addition of Sall4 to the OSK cocktail led to a consistent reverse sequence of locus activation (mir-302 then mir-290) and increased reprogramming efficiency. These results demonstrate that cells can follow multiple paths during the late stages of reprogramming, and that the trajectory of any individual cell is strongly influenced by the combination of factors introduced.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24630794      PMCID: PMC4305531          DOI: 10.1016/j.stem.2014.01.021

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  56 in total

1.  Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells.

Authors:  Bryce W Carey; Styliani Markoulaki; Jacob H Hanna; Dina A Faddah; Yosef Buganim; Jongpil Kim; Kibibi Ganz; Eveline J Steine; John P Cassady; Menno P Creyghton; G Grant Welstead; Qing Gao; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2011-12-02       Impact factor: 24.633

Review 2.  The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC.

Authors:  Marc R Fabian; Nahum Sonenberg
Journal:  Nat Struct Mol Biol       Date:  2012-06-05       Impact factor: 15.369

3.  DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal.

Authors:  Yangming Wang; Rostislav Medvid; Collin Melton; Rudolf Jaenisch; Robert Blelloch
Journal:  Nat Genet       Date:  2007-01-28       Impact factor: 38.330

4.  Naive and primed murine pluripotent stem cells have distinct miRNA expression profiles.

Authors:  Alice Jouneau; Constance Ciaudo; Odile Sismeiro; Vincent Brochard; Luc Jouneau; Sandrine Vandormael-Pournin; Jean-Yves Coppée; Qi Zhou; Edith Heard; Christophe Antoniewski; Michel Cohen-Tannoudji
Journal:  RNA       Date:  2011-12-27       Impact factor: 4.942

5.  Deterministic direct reprogramming of somatic cells to pluripotency.

Authors:  Yoach Rais; Asaf Zviran; Shay Geula; Ohad Gafni; Elad Chomsky; Sergey Viukov; Abed AlFatah Mansour; Inbal Caspi; Vladislav Krupalnik; Mirie Zerbib; Itay Maza; Nofar Mor; Dror Baran; Leehee Weinberger; Diego A Jaitin; David Lara-Astiaso; Ronnie Blecher-Gonen; Zohar Shipony; Zohar Mukamel; Tzachi Hagai; Shlomit Gilad; Daniela Amann-Zalcenstein; Amos Tanay; Ido Amit; Noa Novershtern; Jacob H Hanna
Journal:  Nature       Date:  2013-09-18       Impact factor: 49.962

6.  Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase.

Authors:  Yosef Buganim; Dina A Faddah; Albert W Cheng; Elena Itskovich; Styliani Markoulaki; Kibibi Ganz; Sandy L Klemm; Alexander van Oudenaarden; Rudolf Jaenisch
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

7.  The developmental dismantling of pluripotency is reversed by ectopic Oct4 expression.

Authors:  Rodrigo Osorno; Anestis Tsakiridis; Frederick Wong; Noemí Cambray; Constantinos Economou; Ronald Wilkie; Guillaume Blin; Paul J Scotting; Ian Chambers; Valerie Wilson
Journal:  Development       Date:  2012-07       Impact factor: 6.868

8.  The transcriptional and epigenomic foundations of ground state pluripotency.

Authors:  Hendrik Marks; Tüzer Kalkan; Roberta Menafra; Sergey Denissov; Kenneth Jones; Helmut Hofemeister; Jennifer Nichols; Andrea Kranz; A Francis Stewart; Austin Smith; Hendrik G Stunnenberg
Journal:  Cell       Date:  2012-04-27       Impact factor: 41.582

9.  Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells.

Authors:  Nicola Festuccia; Rodrigo Osorno; Florian Halbritter; Violetta Karwacki-Neisius; Pablo Navarro; Douglas Colby; Frederick Wong; Adam Yates; Simon R Tomlinson; Ian Chambers
Journal:  Cell Stem Cell       Date:  2012-10-05       Impact factor: 24.633

10.  MicroRNA-based discovery of barriers to dedifferentiation of fibroblasts to pluripotent stem cells.

Authors:  Robert L Judson; Tobias S Greve; Ronald J Parchem; Robert Blelloch
Journal:  Nat Struct Mol Biol       Date:  2013-09-15       Impact factor: 15.369

View more
  48 in total

Review 1.  An update on stem cell biology and engineering for brain development.

Authors:  C J C Parr; S Yamanaka; H Saito
Journal:  Mol Psychiatry       Date:  2017-04-04       Impact factor: 15.992

Review 2.  Molecular control of induced pluripotency.

Authors:  Thorold W Theunissen; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2014-06-05       Impact factor: 24.633

3.  High-efficiency cellular reprogramming with microfluidics.

Authors:  Camilla Luni; Stefano Giulitti; Elena Serena; Luca Ferrari; Alessandro Zambon; Onelia Gagliano; Giovanni G Giobbe; Federica Michielin; Sebastian Knöbel; Andreas Bosio; Nicola Elvassore
Journal:  Nat Methods       Date:  2016-04-18       Impact factor: 28.547

4.  An Intermediate Pluripotent State Controlled by MicroRNAs Is Required for the Naive-to-Primed Stem Cell Transition.

Authors:  Peng Du; Mehdi Pirouz; Jiho Choi; Aaron J Huebner; Kendell Clement; Alexander Meissner; Konrad Hochedlinger; Richard I Gregory
Journal:  Cell Stem Cell       Date:  2018-05-24       Impact factor: 24.633

5.  X chromosome reactivation dynamics reveal stages of reprogramming to pluripotency.

Authors:  Vincent Pasque; Jason Tchieu; Rahul Karnik; Molly Uyeda; Anupama Sadhu Dimashkie; Dana Case; Bernadett Papp; Giancarlo Bonora; Sanjeet Patel; Ritchie Ho; Ryan Schmidt; Robin McKee; Takashi Sado; Takashi Tada; Alexander Meissner; Kathrin Plath
Journal:  Cell       Date:  2014-12-18       Impact factor: 41.582

Review 6.  SALL4, the missing link between stem cells, development and cancer.

Authors:  Hiro Tatetsu; Nikki R Kong; Gao Chong; Giovanni Amabile; Daniel G Tenen; Li Chai
Journal:  Gene       Date:  2016-02-16       Impact factor: 3.688

7.  The eutheria-specific miR-290 cluster modulates placental growth and maternal-fetal transport.

Authors:  Alireza Paikari; Cassandra D Belair; Daniel Saw; Robert Blelloch
Journal:  Development       Date:  2017-09-21       Impact factor: 6.868

8.  Integrative Analyses of Human Reprogramming Reveal Dynamic Nature of Induced Pluripotency.

Authors:  Davide Cacchiarelli; Cole Trapnell; Michael J Ziller; Magali Soumillon; Marcella Cesana; Rahul Karnik; Julie Donaghey; Zachary D Smith; Sutheera Ratanasirintrawoot; Xiaolan Zhang; Shannan J Ho Sui; Zhaoting Wu; Veronika Akopian; Casey A Gifford; John Doench; John L Rinn; George Q Daley; Alexander Meissner; Eric S Lander; Tarjei S Mikkelsen
Journal:  Cell       Date:  2015-07-16       Impact factor: 41.582

9.  FOXD3 Regulates Pluripotent Stem Cell Potential by Simultaneously Initiating and Repressing Enhancer Activity.

Authors:  Raga Krishnakumar; Amy F Chen; Marisol G Pantovich; Muhammad Danial; Ronald J Parchem; Patricia A Labosky; Robert Blelloch
Journal:  Cell Stem Cell       Date:  2016-01-07       Impact factor: 24.633

10.  MiR-302/367 regulate neural progenitor proliferation, differentiation timing, and survival in neurulation.

Authors:  Si-Lu Yang; Mei Yang; Stephanie Herrlinger; Chen Liang; Fan Lai; Jian-Fu Chen
Journal:  Dev Biol       Date:  2015-10-09       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.